How long does it take to lose 4 stone on Mounjaro?

What the SURMOUNT-1 trial tells us about larger weight losses

SURMOUNT-1 is the foundational phase 3 trial for tirzepatide used in weight management. It followed 2,539 adults with obesity over 72 weeks (roughly 17 months) and produced some of the strongest weight-loss results recorded for any licensed medicine. At the 15 mg dose, participants lost an average of around 20–21% of their body weight. For someone starting at, say, 130 kg, that is approximately 26–27 kg: just over 4 stone. These figures come from the SURMOUNT-1 paper published in the New England Journal of Medicine.

The key word is average. Some participants lost considerably more; others less. Whether 4 stone falls inside or outside your personal range depends on factors the trial average cannot capture, primarily your starting body weight, the dose your prescriber is able to take you to, and how consistently your appetite and eating patterns shift in response to the medicine. The trial does suggest, though, that for many people with a BMI well above 30, a 4-stone loss is a realistic ceiling rather than an aspirational one.

It is also worth knowing that SURMOUNT-1 combined Mounjaro with a reduced-calorie diet and increased activity. The medicine does a great deal of the work by reducing appetite, but the lifestyle component still contributed to the results. Our full Mounjaro overview explains how the dual GIP and GLP-1 mechanism underpins those reductions.

Why the 12–18 month window is realistic for 4 stone

Treatment opens at 2.5 mg, a starting dose chosen to let your system adjust gradually, not to produce rapid weight loss. Your prescriber then increases the dose roughly every four weeks: to 5 mg, then 7.5 mg, and so on, up to a maximum of 15 mg if tolerated. That titration ladder means the dose doing the heaviest lifting often is not reached until month three or four at the earliest.

Once you reach an effective maintenance dose, the rate of loss tends to be steadiest. Clinical data suggest most of the weight reduction happens in the first year, with slower but continued progress beyond that. For a goal of 4 stone specifically, a realistic working estimate is 12 to 18 months from your first injection, closer to 12 if you respond well to a higher dose, closer to 18 or beyond if you plateau at a lower one or if your starting BMI means a proportionally larger total loss is needed. If you want a sense of the earlier milestones, losing 2 stone on Mounjaro is often achievable within six to nine months for people who titrate steadily.

A practical checking habit: once a month, note your weight at the same time of day on the same scales. A single month's number tells you little; three months of readings in a row shows the genuine trend. That small routine makes it much easier to have a productive conversation with your prescriber at each review.

The factors that speed up (or slow down) your progress

No two people follow the same curve, and understanding what drives the variation makes the timeline less daunting. Starting weight matters more than many people expect: a heavier starting point usually means a faster absolute loss in the early months, because even a modest percentage reduction translates to several kilograms. Conversely, someone starting closer to the eligibility threshold may find the final few pounds of a 4-stone goal the hardest to shift.

Dose reached is probably the single biggest clinical variable. Not everyone tolerates or needs 15 mg; some people achieve their goals at 10 mg. NICE's appraisal of tirzepatide (TA1026, published December 2024) notes that if less than 5% weight loss has been achieved after six months at the highest tolerated dose, continuing should be reviewed. That is not a ceiling on ambition; it is a clinical checkpoint designed to make sure the medicine is working for you.

Diet composition, sleep quality, stress and underlying conditions such as hypothyroidism can all influence the rate of loss. Mounjaro significantly reduces appetite, but protein intake and hydration still matter during treatment to preserve muscle and manage the most common side effects. Our weight-loss treatment overview covers the broader picture of what supports good outcomes alongside GLP-1 medicines.

For context on what losing a smaller amount looks like earlier in treatment, the 1-stone timeline page sets out typical early milestones. And if 4 stone is actually the midpoint of your goal, our page on losing 6 stone on Mounjaro covers what extended treatment looks like in the trial data.

How a prescriber turns evidence into a plan for you

The timelines above come from population averages. What matters to you is your timeline, and that requires an individual clinical assessment, not a calculator. A GPhC-registered Independent Prescriber looks at your full health picture: current weight, weight-related conditions, any medicines you already take, and your history with other weight-management approaches. They set the titration schedule, monitor your progress at each repeat, and adjust the plan if needed.

That clinical oversight does not stop after the first pen. At every repeat, a prescriber reviews whether treatment is working, whether the dose is appropriate, and whether anything has changed. If you are already on Mounjaro elsewhere and want to understand how your current trajectory compares to the trial evidence, our guide to how quickly Mounjaro starts working may be useful.

For those interested in whether a heavier starting point changes the picture, the 5-stone timeline addresses what that goal typically looks like in the data. And if you are weighing up the cost of sustained treatment, the context on Mounjaro's UK pricing is worth reading before you start. When you are ready to talk through your own situation with a prescriber, you can start your free consultation with our clinical team.